LSL Pharma Group Inc. — AGM Information 2024

Jun 6, 2024

==> picture [93 x 57] intentionally omitted <==

==> picture [68 x 30] intentionally omitted <==

Appointment of a proxyholder

2. Appointment of Auditors

Appointment of KPMG LLP as Auditors of the Corporation for the ensuing year and authorize the Directors to fix their compensation.

==> picture [101 x 42] intentionally omitted <==

----- Start of picture text -----

FOR WITHHOLD
FOR AGAINST WITHHOLD
----- End of picture text -----

3. Approval of the Stock Option Plan

As holder(s) of Class A Common shares of LSL Pharma Group Inc. (the “Corporation “), I/we hereby appoint: François Roberge, Chairman of the Board, President and Chief Executive Officer, or failing him, Sylvain Aird, Director and Secretary of the Corporation, or

---

Print the name of the person you are appointing if this person is someone other than the individuals listed hereinabove.

as proxyholder with full power of substitution to attend, act and vote for and on behalf of the undersigned in accordance with the following directions (or if no directions have been given, as the proxyholder sees fit) and all other matters that may properly come before the Annual and Special Meeting of Shareholders of the Corporation (the “Meeting”) to held at 1250 René Lévesque Blvd. West, 20th Floor, Montréal, Québec, H3B 4W8, on June 28, 2024, at 10:00 a.m. (Eastern time), by conference call and online by webcast, or at any adjournment or postponement thereof, in the same manner, to the same extent and with the same powers as if the undersigned was/were personally present. To instantly join the conference call by phone, please use the following link to easily register close to the call start time. After registering, the system will call you instantly and connect you into the conference call automatically: https://emportal.ink/3wN8TXe. Alternatively, you may dial in to the conference call by calling 1-888-664-6392 or 416-764-8659 and you will be connected to the call by an operator. You may also stream the call by webcast by following this link: https://app.webinar.net/wDdB9RDo2YQ.

I/We authorize you to act in accordance with my/our instructions set out above. I/We hereby revoke any VIF previously given with respect to the Meeting. If no voting instructions are indicated above, this VIF will be voted FOR a matter by Management’s appointees or, if you appoint another proxyholder, as such other proxyholder sees fit. On any amendments or variations proposed or any new business properly submitted before the Meeting, I/We authorize you to vote as you see fit.

_________ ____ Signature(s) Date

Please sign exactly as your name(s) appear on this VIF. Please see reverse for instructions. All VIFs must be received by June 26, 2024, at 10:00 a.m. ET.

The Corporation’s Board of Directors recommends voting FOR all of the following resolutions. Please use a black pen or a dark pencil.

1. Election	of Directors	FOR	AGAINST
1.	Diane Beaudry
2.	Frank J. Dellafera
3.	Stuart William Fowler
4.	Pierre B. Lafrenière
5.	Mario Paradis
6.	François Roberge
7.	Giuseppe Soccodato

Voting Instruction Form (“VIF”) – Annual and Special Meeting of Shareholders of LSL Pharma Group Inc. to be held on June 28 2024, at 10:00 a.m. ET (the “Meeting”)

INTERNET

How to Vote

TELEPHONE

Notes

1. We are sending to you the enclosed proxy-related materials that relate to the Meeting of the holders of the series or class of securities that are held on your behalf by the intermediary identified above. Unless you attend the Meeting and vote in person, your securities can be voted only by management, as proxy holder of the registered holder, in accordance with your instructions.

2. We are prohibited from voting these securities on any of the matters to be acted upon at the Meeting without your specific voting instructions. In order for these securities to be voted at the Meeting, it will be necessary for us to have your specific voting instructions. Please complete and return the information requested in this VIF to provide your voting instructions to us promptly.

3. If you want to attend the meeting and vote in person, please write your name in the place provided for that purpose in this form. You can also write the name of someone else whom you wish to attend the meeting and vote on your behalf. Unless prohibited by law, the person whose name is written in the space provided will have full authority to present matters to the meeting and vote on all matters that are presented at the meeting, even if those matters are not set out in this form or the Circular. Consult a legal advisor if you wish to modify the authority of that person in any way. If you require help, please contact the Registered Representative who services your account.

4. This VIF should be signed by you in the exact manner as your name appears on the VIF. If these voting instructions are given on behalf of a body corporate set out the full legal name of the body corporate, the name and position of the person giving voting instructions on behalf of the body corporate and the address for service of the body corporate.

5. If this VIF is not dated, it will be deemed to bear the date on which it is mailed on behalf of management to you.

6. Go to www.meeting-vote.comwww.meeting-vote.com-vote.comvote.com

7. Go to www.meeting-vote.comwww.meeting-vote.com-vote.comvote.com Use any touch-tone phone, call toll

8. Cast your vote online free in Canada and the United  View Meeting documents States 1-888-489-7352 , an agent will help you vote online.

To vote by Internet or telephone you will need your control number. If you vote by Internet or telephone, do not return this VIF.

MAIL, FAX OR EMAIL

• Complete and return your signed VIF in the envelope provided or send to:

TSX Trust Company P.O. Box 721 Agincourt, ON M1S 0A1

• You may alternatively fax your proxy to 416-595-9593 or scan and email to proxyvote@tmx.com.

All VIFs must be received by June 26, 2024, at 10:00 a.m. ET.

1. When properly signed and delivered, securities represented by this VIF will be voted as directed by you, however, if such a direction is not made in respect of any matter, the VIF will direct the voting of the securities to be made as recommended in the documentation provided by Management for the Meeting.

2. This VIF confers discretionary authority on the appointee to vote as the appointee sees fit in respect of amendments or variations to matters identified in the notice of Meeting or other matters as may properly come before the Meeting or any adjournment thereof.

3. Your voting instructions will be recorded on receipt of the VIF.

4. By providing voting instructions as requested, you are acknowledging that you are the beneficial owner of and are entitled to instruct us with respect to the voting of, these securities.

5. If you have any questions regarding the enclosed documents, please contact the Registered Representative who services your account.

6. This VIF should be read in conjunction with the Circular and other proxy materials provided by Management.

==> picture [95 x 40] intentionally omitted <==